Yüklüyor......
Pan-Cancer Analysis and Drug Formulation for GPR139 and GPR142
GPR (G protein receptor) 139 and 142 are novel foundling GPCRs (G protein-coupled receptors) in the class “A” of the GPCRs family and are suitable targets for various biological conditions. To engage these targets, validated pharmacophores and 3D QSAR (Quantitative structure-activity relationship) m...
Kaydedildi:
| Yayımlandı: | Front Pharmacol |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7933564/ https://ncbi.nlm.nih.gov/pubmed/33679382 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.521245 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|